High Tech Pharm하이텍팜
106190 · KOSDAQ · ₩106190 · 하이텍팜
₩8,800▼ ₩180 (2.00%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 27.3% | 24.1% | 25.1% | 16.7% | 7.6% | 4.2% |
| Operating margin | 17.7% | 18.3% | 20.1% | 13.1% | 4.8% | −0.6% |
| Net margin | 17.2% | 16.4% | 17.7% | 10.5% | 5.7% | −1.7% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −1.1% | −9.5% | +1.0% | −25.4% | +40.5% | — |
| Operating income growth | −4.5% | −17.4% | +54.2% | +104.8% | +1,295.9% | — |
| Net income growth | +3.9% | −16.3% | +69.8% | +37.5% | +579.3% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 9.0% | 9.2% | 12.1% | 7.8% | 6.1% | −1.3% |
| Return on assets | 8.2% | 8.1% | 10.0% | 6.0% | 4.6% | −1.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 10.3% | 10.0% | 17.0% | 26.2% | 32.3% | 30.9% |
| Net debt to equity | — | −10.0% | 0.2% | 10.4% | 8.5% | 5.0% |
| Current ratio | 586.9% | 567.1% | 339.0% | 248.3% | 164.0% | 178.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: High Tech Pharm / 하이텍팜 / 106190 / KRX:106190
Source: KRX statistical information